| 5DRR: reference: Drug design from the cryptic inhibitor envelope., Lee CJ, Liang X, Wu Q, Najeeb J, Zhao J, Gopalaswamy R, Titecat M, Sebbane F, Lemaitre N, Toone EJ, Zhou P, Nat Commun. 2016 Feb 25;7:10638. doi: 10.1038/ncomms10638. PMID: 26912110 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).